期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

卡培他滨致手足综合征的发生规律及治疗进展 被引量：14

暂未订购
导出
摘要 手足综合征（hand—foot svndrome，HFS）在1984年由哈佛医学院英格兰戴肯尼斯医院的Jacob Lokich和Chery Moore进行了报道，当时观察到在长期反复接受5氟尿培啶（5-Fu）或脂质体阿霉素化疗的患者中有25％会发生这种特异性皮肤综合征，HFS又称为掌跖感觉丧失性红斑综合征（palmar—planter erytllmdysesthesia syndrome，PPES），临床主要表现为指／趾的热、痛、红斑性肿胀，
作者 娄彦妮 贾立群
机构地区 中日友好医院中医肿瘤科
出处 《中日友好医院学报》 2008年第3期176-178,共3页 Journal of China-Japan Friendship Hospital
关键词 手足综合征 发生规律 卡培他滨 掌跖感觉丧失性红斑 治疗 脂质体阿霉素 哈佛医学院 皮肤综合征
分类号 R595.3 [医药卫生—内科学]
  • 相关文献

参考文献23

  • 1Lokich JJ,Moore C.Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome[J].Ann Intern Med,1984,101(6):798-799.
  • 2Blum JL,Jones SE,Buzdar AU,et al.Multicenter phaseⅡstudy of capecitabine in paclitaxel-refractory etastatic breast cancer[J].J Clin Oncol,1999,17(2):485-493.
  • 3Blum JL,Dieras V,Lo Rnsso PM,et al.Multicenter,phase Ⅱ study of capecitabine in taxane-pretreated metastatic breast carcinoma patients[J].Caneer,2001,92(7):1759-1768.
  • 4Reichardt P,Von Minckwitz G,Thuss-Patience PC,et al.Multicenter phase Ⅱstudy of oral capecitabine (Xeloda) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy[J].Ann Oneol,2003,14(8):1227-1233.
  • 5Hoff PM,Ansari R,Batist G,et al.Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer:results of a randomized Phase Ⅲ study[J].J Clin Oneol,2001,19(8):2282-2292.
  • 6Van Cutsem E,Twelves C,Cassidy J,et al.Oral capecitabine compared with intravenous fluorouracil pins leucovorin in patients with metastatic colorectal cancer:results of a large Phase Ⅲ study[J].J Clin Oncol,2001,19(21):4097-4106.
  • 7O'Shaughnessy J,Miles D,Vukelja S,et al.Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer:phase Ⅲ trial results[J].J Clin Oneol,2002,20(12):2812-2823.
  • 8Miller KD,Chap LI,Holmes FA,et al.Randomized phase Ⅲ trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer[J].J Clin Oncol,2005,23(4):792-799.
  • 9Scheithauer W,McKendrick J,Begbie S,et al.Oral capecitabine as an alternative to i.v.5-fluorouracil-based adjuvant therapy for colon cancer:safety results of a randomized,phase Ⅲ trial[J].Ann Oncol,2003,14 (12):1735-1743.
  • 10Twelves C,Wong A,Nowacki MP,et al.Capecitabine as adjuvant treatment for stage Ⅲ colon cancer[J].N Engl J Med,2005,352(26):2696-2704.

二级参考文献11

  • 1[1]Blum JL, Jones SE, Buzdar AU, et al. Multicenter phase Ⅱ study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol, 1999, 17 (2):485
  • 2[2]Talbot DC, Moiseyenko V, Van Belle S, et al. Randomised,phase Ⅱ trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreatedwith anthracyclines. Br J Cancer, 2002, 86 (9):1367
  • 3[3]Meta-analysis goup in cancer. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced coleorectal cancer. J Clin Oneol. 1998, 16:301
  • 4[4]Meta-analysis group in carcer. Toxicity of fiuorouracil in patients with advanced colorectal cancer: Effect of administration schedule and prognostic factors. J Clin Oncol, 1998, 16:3537
  • 5[5]Lokich JJ, Moore C. Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome. Ann Inter Med, 1984, 101 :798
  • 6[6]Blum JL, Jones SE, Buzdar AU, et al. Multicenter phase Ⅱ study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol, 1999, 17 (2) :485
  • 7[7]Vukelja SJ, Lombardo FA, James WD, et al. Pyridoxine for the palar-plantar erythrodysesthesia syndrome. Ann Inter Med,1989, 111:688
  • 8[8]Fabian CJ, Molina R, Slavik M, et al. Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion. Invest New Drugs, 1990, 8:57
  • 9[9]Jucgla A, Sais G. Hand-foot syndrome. J Clin Oncol, 1997, 15: 3164
  • 10[10]Mortimer JE, Anderson I. Weekly fluorouracil and high-dose leucovorin: Efficacy and treatment of cutaneous toxicity. Cancer Chemother Pharmacol, 1990, 26:449

共引文献66

同被引文献92

引证文献14

二级引证文献59

中日友好医院学报
2008年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部